{"name": "Biolex Therapeutics",
 "permalink": "biolex-therapeutics",
 "crunchbase_url": "http://www.crunchbase.com/company/biolex-therapeutics",
 "homepage_url": "http://www.biolex.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": 105,
 "founded_year": 1997,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "biotech, hepatitis, clinical-stage, locteron, lemna, therapeutic",
 "alias_list": "",
 "email_address": "info@biolex.com",
 "phone_number": "919.542.9901",
 "description": "Healthcare Biotechnology",
 "created_at": "Mon Jun 22 19:58:08 UTC 2009",
 "updated_at": "Sat Oct 30 01:57:40 UTC 2010",
 "overview": "\u003Cp\u003EBiolex is a clinical-stage biopharmaceutical company that uses their patented LEX SystemSM to develop hard-to-make therapeutic proteins and monoclonal antibodies that have been optimized to enhance their efficacy and potency. The LEX System is a technology that genetically transforms the aquatic plant Lemna to enable the production of biologic product candidates. Their main product aims at treating those afflicted with Hepatitis C. \u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       50],
      "assets/images/resized/0005/0190/50190v1-max-150x150.png"],
     [[250,
       84],
      "assets/images/resized/0005/0190/50190v1-max-250x250.png"],
     [[263,
       89],
      "assets/images/resized/0005/0190/50190v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "Director ",
    "person":
     {"first_name": "Kevin",
      "last_name": "Bitterman",
      "permalink": "kevin-bitterman",
      "image":
       {"available_sizes":
         [[[100,
            150],
           "assets/images/resized/0025/1971/251971v1-max-150x150.jpg"],
          [[150,
            225],
           "assets/images/resized/0025/1971/251971v1-max-250x250.jpg"],
          [[150,
            225],
           "assets/images/resized/0025/1971/251971v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "Director",
    "person":
     {"first_name": "Kyle",
      "last_name": "Chenet",
      "permalink": "kyle-chenet",
      "image": null}},
   {"is_past": true,
    "title": "President and CEO",
    "person":
     {"first_name": "Jan",
      "last_name": "Turek",
      "permalink": "jan-turek",
      "image":
       {"available_sizes":
         [[[150,
            150],
           "assets/images/resized/0027/5221/275221v1-max-150x150.jpg"],
          [[200,
            200],
           "assets/images/resized/0027/5221/275221v1-max-250x250.jpg"],
          [[200,
            200],
           "assets/images/resized/0027/5221/275221v1-max-450x450.jpg"]],
        "attribution": ""}}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$154M",
 "funding_rounds":
  [{"round_code": "d",
    "source_url": "http://www.mitsuiventures.com/en/investment/news/2008/20081006.html",
    "source_description": "Biolex Therapeutics Completes $60 Million Series D Financing to Accelerate Development of Locteron\u00c2\u00ae in Hepatitis C",
    "raised_amount": 60000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2008,
    "funded_month": 10,
    "funded_day": 6,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Dow Venture Capital",
         "permalink": "dow-venture-capital",
         "image":
          {"available_sizes":
            [[[150,
               40],
              "assets/images/resized/0002/8886/28886v1-max-150x150.png"],
             [[165,
               45],
              "assets/images/resized/0002/8886/28886v1-max-250x250.png"],
             [[165,
               45],
              "assets/images/resized/0002/8886/28886v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Johnson \u0026 Johnson Development Corporation",
         "permalink": "johnson-johnson-development-corporation",
         "image":
          {"available_sizes":
            [[[150,
               57],
              "assets/images/resized/0005/8402/58402v1-max-150x150.png"],
             [[225,
               86],
              "assets/images/resized/0005/8402/58402v1-max-250x250.png"],
             [[225,
               86],
              "assets/images/resized/0005/8402/58402v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Clarus Ventures",
         "permalink": "clarus-ventures",
         "image":
          {"available_sizes":
            [[[150,
               82],
              "assets/images/resized/0005/0042/50042v2-max-150x150.png"],
             [[250,
               137],
              "assets/images/resized/0005/0042/50042v2-max-250x250.png"],
             [[308,
               169],
              "assets/images/resized/0005/0042/50042v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Quaker BioVentures",
         "permalink": "quaker-bioventures",
         "image":
          {"available_sizes":
            [[[144,
               96],
              "assets/images/resized/0004/9249/49249v2-max-150x150.jpg"],
             [[144,
               96],
              "assets/images/resized/0004/9249/49249v2-max-250x250.jpg"],
             [[144,
               96],
              "assets/images/resized/0004/9249/49249v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Bioventures Investors",
         "permalink": "bioventures-investors",
         "image":
          {"available_sizes":
            [[[150,
               36],
              "assets/images/resized/0005/5091/55091v1-max-150x150.png"],
             [[195,
               48],
              "assets/images/resized/0005/5091/55091v1-max-250x250.png"],
             [[195,
               48],
              "assets/images/resized/0005/5091/55091v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "J.P. Morgan Securities Inc.",
         "permalink": "j-p-morgan-securities-inc",
         "image":
          {"available_sizes":
            [[[150,
               32],
              "assets/images/resized/0006/7739/67739v1-max-150x150.png"],
             [[188,
               41],
              "assets/images/resized/0006/7739/67739v1-max-250x250.png"],
             [[188,
               41],
              "assets/images/resized/0006/7739/67739v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "InterSouth Partners",
         "permalink": "intersouth-partners",
         "image":
          {"available_sizes":
            [[[150,
               43],
              "assets/images/resized/0002/9315/29315v2-max-150x150.png"],
             [[250,
               71],
              "assets/images/resized/0002/9315/29315v2-max-250x250.png"],
             [[403,
               116],
              "assets/images/resized/0002/9315/29315v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "OrbiMed Advisors",
         "permalink": "orbimed-advisors",
         "image":
          {"available_sizes":
            [[[150,
               42],
              "assets/images/resized/0005/0248/50248v1-max-150x150.png"],
             [[203,
               58],
              "assets/images/resized/0005/0248/50248v1-max-250x250.png"],
             [[203,
               58],
              "assets/images/resized/0005/0248/50248v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "L.L.C.",
         "permalink": "l-l-c",
         "image": null},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Dogwood Equity",
         "permalink": "dogwood-equity",
         "image":
          {"available_sizes":
            [[[150,
               44],
              "assets/images/resized/0005/8524/58524v1-max-150x150.jpg"],
             [[195,
               58],
              "assets/images/resized/0005/8524/58524v1-max-250x250.jpg"],
             [[195,
               58],
              "assets/images/resized/0005/8524/58524v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Investor Growth Capital",
         "permalink": "investor-growth-capital",
         "image":
          {"available_sizes":
            [[[107,
               31],
              "assets/images/resized/0002/9321/29321v1-max-150x150.png"],
             [[107,
               31],
              "assets/images/resized/0002/9321/29321v1-max-250x250.png"],
             [[107,
               31],
              "assets/images/resized/0002/9321/29321v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Mitsui Ventures",
         "permalink": "mitsui-ventures",
         "image":
          {"available_sizes":
            [[[150,
               18],
              "assets/images/resized/0002/0633/20633v1-max-150x150.png"],
             [[250,
               31],
              "assets/images/resized/0002/0633/20633v1-max-250x250.png"],
             [[250,
               31],
              "assets/images/resized/0002/0633/20633v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "c",
    "source_url": "http://biolex.com/pdfs/Biolex%20-%20Series%20C%20Press%20Release%20-%20May%2024,%202007.pdf",
    "source_description": "BIOLEX THERAPEUTICS RAISES $30 MILLION TO ADVANCE ITS HEPATITIS C DRUG CANDIDATE AND OTHER PIPELINE PROGRAMS",
    "raised_amount": 30000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2007,
    "funded_month": 5,
    "funded_day": 24,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Investor Growth Capital",
         "permalink": "investor-growth-capital",
         "image":
          {"available_sizes":
            [[[107,
               31],
              "assets/images/resized/0002/9321/29321v1-max-150x150.png"],
             [[107,
               31],
              "assets/images/resized/0002/9321/29321v1-max-250x250.png"],
             [[107,
               31],
              "assets/images/resized/0002/9321/29321v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "JP Morgan",
         "permalink": "jp-morgan",
         "image":
          {"available_sizes":
            [[[141,
               29],
              "assets/images/resized/0025/1100/251100v1-max-150x150.png"],
             [[141,
               29],
              "assets/images/resized/0025/1100/251100v1-max-250x250.png"],
             [[141,
               29],
              "assets/images/resized/0025/1100/251100v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Easton Capital",
         "permalink": "easton-capital",
         "image":
          {"available_sizes":
            [[[150,
               51],
              "assets/images/resized/0001/6203/16203v3-max-150x150.jpg"],
             [[208,
               72],
              "assets/images/resized/0001/6203/16203v3-max-250x250.jpg"],
             [[208,
               72],
              "assets/images/resized/0001/6203/16203v3-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Quaker BioVentures",
         "permalink": "quaker-bioventures",
         "image":
          {"available_sizes":
            [[[144,
               96],
              "assets/images/resized/0004/9249/49249v2-max-150x150.jpg"],
             [[144,
               96],
              "assets/images/resized/0004/9249/49249v2-max-250x250.jpg"],
             [[144,
               96],
              "assets/images/resized/0004/9249/49249v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Polaris Partners",
         "permalink": "polaris-partners",
         "image":
          {"available_sizes":
            [[[150,
               36],
              "assets/images/resized/0001/1153/11153v1-max-150x150.png"],
             [[163,
               40],
              "assets/images/resized/0001/1153/11153v1-max-250x250.png"],
             [[163,
               40],
              "assets/images/resized/0001/1153/11153v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "InterSouth Partners",
         "permalink": "intersouth-partners",
         "image":
          {"available_sizes":
            [[[150,
               43],
              "assets/images/resized/0002/9315/29315v2-max-150x150.png"],
             [[250,
               71],
              "assets/images/resized/0002/9315/29315v2-max-250x250.png"],
             [[403,
               116],
              "assets/images/resized/0002/9315/29315v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Mitsui Ventures",
         "permalink": "mitsui-ventures",
         "image":
          {"available_sizes":
            [[[150,
               18],
              "assets/images/resized/0002/0633/20633v1-max-150x150.png"],
             [[250,
               31],
              "assets/images/resized/0002/0633/20633v1-max-250x250.png"],
             [[250,
               31],
              "assets/images/resized/0002/0633/20633v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Johnson \u0026 Johnson Development",
         "permalink": "johnson-johnson-development",
         "image":
          {"available_sizes":
            [[[150,
               61],
              "assets/images/resized/0003/2806/32806v1-max-150x150.png"],
             [[206,
               85],
              "assets/images/resized/0003/2806/32806v1-max-250x250.png"],
             [[206,
               85],
              "assets/images/resized/0003/2806/32806v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Dow Venture Capital",
         "permalink": "dow-venture-capital",
         "image":
          {"available_sizes":
            [[[150,
               40],
              "assets/images/resized/0002/8886/28886v1-max-150x150.png"],
             [[165,
               45],
              "assets/images/resized/0002/8886/28886v1-max-250x250.png"],
             [[165,
               45],
              "assets/images/resized/0002/8886/28886v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "b",
    "source_url": "http://biolex.com/pdfs/Biolex%20Raises%20$36M.pdf",
    "source_description": "BIOLEX THERAPEUTICS RAISES $36 MILLION IN VENTURE FINANCING",
    "raised_amount": 36000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2005,
    "funded_month": 9,
    "funded_day": 1,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Polaris Partners",
         "permalink": "polaris-partners",
         "image":
          {"available_sizes":
            [[[150,
               36],
              "assets/images/resized/0001/1153/11153v1-max-150x150.png"],
             [[163,
               40],
              "assets/images/resized/0001/1153/11153v1-max-250x250.png"],
             [[163,
               40],
              "assets/images/resized/0001/1153/11153v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "InterSouth Partners",
         "permalink": "intersouth-partners",
         "image":
          {"available_sizes":
            [[[150,
               43],
              "assets/images/resized/0002/9315/29315v2-max-150x150.png"],
             [[250,
               71],
              "assets/images/resized/0002/9315/29315v2-max-250x250.png"],
             [[403,
               116],
              "assets/images/resized/0002/9315/29315v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Quaker BioVentures",
         "permalink": "quaker-bioventures",
         "image":
          {"available_sizes":
            [[[144,
               96],
              "assets/images/resized/0004/9249/49249v2-max-150x150.jpg"],
             [[144,
               96],
              "assets/images/resized/0004/9249/49249v2-max-250x250.jpg"],
             [[144,
               96],
              "assets/images/resized/0004/9249/49249v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Johnson \u0026 Johnson Development Corporation",
         "permalink": "johnson-johnson-development-corporation",
         "image":
          {"available_sizes":
            [[[150,
               57],
              "assets/images/resized/0005/8402/58402v1-max-150x150.png"],
             [[225,
               86],
              "assets/images/resized/0005/8402/58402v1-max-250x250.png"],
             [[225,
               86],
              "assets/images/resized/0005/8402/58402v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Mitsui Ventures",
         "permalink": "mitsui-ventures",
         "image":
          {"available_sizes":
            [[[150,
               18],
              "assets/images/resized/0002/0633/20633v1-max-150x150.png"],
             [[250,
               31],
              "assets/images/resized/0002/0633/20633v1-max-250x250.png"],
             [[250,
               31],
              "assets/images/resized/0002/0633/20633v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Kitty Hawk Capital",
         "permalink": "kitty-hawk-capital",
         "image": null},
       "person": null}]},
   {"round_code": "unattributed",
    "source_url": "",
    "source_description": "EDGAR",
    "raised_amount": 8000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2005,
    "funded_month": 1,
    "funded_day": 7,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Johnson \u0026 Johnson Development Corporation",
         "permalink": "johnson-johnson-development-corporation",
         "image":
          {"available_sizes":
            [[[150,
               57],
              "assets/images/resized/0005/8402/58402v1-max-150x150.png"],
             [[225,
               86],
              "assets/images/resized/0005/8402/58402v1-max-250x250.png"],
             [[225,
               86],
              "assets/images/resized/0005/8402/58402v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "d",
    "source_url": "https://www.fis.dowjones.com/article.aspx?ProductIDFromApplication=32\u0026aid=DJFVW00020101029e6at00001\u0026r=Rss\u0026s=DJFVW",
    "source_description": "Biolex Gets $20M From Insiders, Sees Strong Data From Hepatitis C Drug ",
    "raised_amount": 20000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 10,
    "funded_day": 29,
    "investments":
     []}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "Headquarters",
    "address1": "158 Credle Street",
    "address2": "",
    "zip_code": "27312",
    "city": "Pittsboro",
    "state_code": "NC",
    "country_code": "USA",
    "latitude": 35.7259177,
    "longitude": -79.1791771}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        93],
       "assets/images/resized/0005/0189/50189v1-max-150x150.png"],
      [[250,
        155],
       "assets/images/resized/0005/0189/50189v1-max-250x250.png"],
      [[450,
        280],
       "assets/images/resized/0005/0189/50189v1-max-450x450.png"]],
    "attribution": null}],
 "external_links":
  []}